MONDAY, Jan. 30, 2023 (HealthDay News) — If you find yourself stuck in a traffic jam and you start to feel fuzzy-headed, the diesel exhaust from the truck in front of you might be to blame. New research found that just two hours of exposure to diesel exhaust impaired theContinue Reading
MONDAY, Jan. 30, 2023 (HealthDay News) — Many adults with epilepsy have agoraphobia, or a fear of public places, new research suggests. That impacts quality of life and is something doctors should include in other screening that looks for anxiety or depression, the investigators said. “We know that agoraphobia canContinue Reading
THURSDAY, Jan. 26, 2023 (HealthDay News) — People who suffer a heart attack or stroke in middle age may develop memory and thinking problems earlier in life, too, a new study finds. The study, published online Jan. 25 in the journal Neurology, focused on people who had developed premature cardiovascularContinue Reading
WEDNESDAY, Jan. 25, 2023 (HealthDay News) — Memory loss is the most common symptom associated with Alzheimer’s disease — the terrifying prospect of slowly forgetting yourself and everything around you. But people who exhibit memory loss early on in their dementia actually have a slower rate of decline than thoseContinue Reading
TUESDAY, Jan. 24, 2023 (HealthDay News) — Any ‘middle-age spread’ of excess weight around your tummy could raise your risk of becoming frail decades later, a new study suggests. Obese folks who’ve packed on pounds around their waist are more likely to develop symptoms of frailty, including exhaustion, weak gripContinue Reading
MONDAY, Jan. 23, 2023 (HealthDay News) — When kids suffer a concussion, an extended period of rest at home is always the best course, right? Perhaps not. In fact, a new study suggests that — despite what many people may presume — getting kids back to school quickly is theContinue Reading
THURSDAY, Jan. 19, 2023 (HealthDay News) — By the time they’re teenagers, babies born prematurely may be getting poorer school grades than their non-preemie peers. Researchers found that babies born before 34 weeks of pregnancy had lower scores on math and language tests during their teen years compared to kidsContinue Reading
THURSDAY, Jan. 19, 2023 (HealthDay News) — Some college athletes take longer to recover from a concussion, but a new study offers them some good news. They may still be able to return to play — after one extra month of recovery, researchers report Jan. 18 in the journal Neurology.Continue Reading
THURSDAY, Jan. 19, 2023 (HealthDay News) — A recent study suggests that Parkinson’s disease, in which parts of the brain are progressively damaged over many years, may actually start in the gut. Nearly 30% of the gut bacteria in patients with Parkinson’s disease differed from those without the disease, accordingContinue Reading
THURSDAY, Jan. 12, 2023 (HealthDay News) — American adults who have epilepsy and are Black or Hispanic are less likely than white adults to be prescribed the latest medications, according to new research. “While finding the right medication is often a trial-and-error process that is based on the individual, studiesContinue Reading
THURSDAY, Jan. 12, 2023 (HealthDay News) — Six minutes of high-intensity exercise might prolong the lifespan of a healthy brain, perhaps delaying the start of Alzheimer’s and Parkinson’s diseases, a new, small study suggests. Researchers found that short but intense cycling increased the production of a protein called brain-derived neurotrophicContinue Reading
MONDAY, Jan. 9, 2023 (HealthDay News) — Children with autism often have difficulty grasping the emotional cues in other people’s voices, and now researchers may have zeroed in on the reason why. In a study of 43 kids with and without autism, researchers were able to trace such difficulties toContinue Reading
FRIDAY, Jan. 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a second Alzheimer’s drug, lecanemab, despite reports of rare brain bleeds linked to use of the drug in some patients. However, the FDA pointed to the drug’s benefits, as well. “Alzheimer’s disease immeasurably incapacitatesContinue Reading
THURSDAY, Jan. 5, 2023 (HealthDay News) — Lecanemab: It’s an experimental medication that’s been shown in trials to slow cognitive decline in people with Alzheimer’s disease. It’s also up for accelerated approval by the U.S. Food and Drug Administration, with a decision expected by Jan. 6. However, the drug hasContinue Reading